Annette Staebler

8.5k total citations · 2 hit papers
125 papers, 4.8k citations indexed

About

Annette Staebler is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Annette Staebler has authored 125 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 42 papers in Reproductive Medicine and 37 papers in Obstetrics and Gynecology. Recurrent topics in Annette Staebler's work include Ovarian cancer diagnosis and treatment (33 papers), Endometrial and Cervical Cancer Treatments (30 papers) and Breast Cancer Treatment Studies (20 papers). Annette Staebler is often cited by papers focused on Ovarian cancer diagnosis and treatment (33 papers), Endometrial and Cervical Cancer Treatments (30 papers) and Breast Cancer Treatment Studies (20 papers). Annette Staebler collaborates with scholars based in Germany, United States and Switzerland. Annette Staebler's co-authors include Tanja Fehm, D. Wallwiener, Brigitte M. Ronnett, Michael Untch, Gϋnter von Minckwitz, Valentina Nekljudova, Barbara Fleige, Cornelia Liedtke, G Helms and Annette Lebeau and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Annette Staebler

121 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

2013 928 citations Tanja Fehm, Gϋnter von Minckwitz et al. profile →
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

2018 490 citations Stefan Kommoss, Florin‐Andrei Taran et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annette Staebler Germany	33	1.8k	1.5k	1.2k	1.1k	1.1k	125	4.8k
Oluwole Fadare United States	36	1.0k 0.6×	953 0.7×	690 0.6×	1.5k 1.3×	1.4k 1.3×	255	4.7k
Brooke E. Howitt United States	45	1.1k 0.6×	2.1k 1.5×	1.0k 0.9×	1.9k 1.7×	2.0k 1.9×	156	6.7k
Patricia Pautier France	33	600 0.3×	1.8k 1.3×	568 0.5×	1.1k 1.0×	1.5k 1.3×	200	4.8k
Russell Vang United States	52	1.2k 0.7×	1.9k 1.3×	1.3k 1.1×	2.1k 1.9×	4.1k 3.8×	169	7.9k
G. Gitsch Austria	35	811 0.5×	1.0k 0.7×	340 0.3×	834 0.7×	762 0.7×	166	3.7k
Carmen Tornos United States	38	571 0.3×	916 0.6×	750 0.6×	1.9k 1.7×	2.0k 1.8×	91	4.4k
Claes G. Tropé Norway	36	787 0.4×	1.2k 0.8×	313 0.3×	928 0.8×	1.2k 1.1×	149	3.8k
Satoru Sagae Japan	28	626 0.3×	731 0.5×	396 0.3×	982 0.9×	1.3k 1.2×	75	3.0k
Kay J. Park United States	41	741 0.4×	1.4k 1.0×	373 0.3×	3.1k 2.8×	2.1k 1.9×	149	5.8k
Deborah F. DeLair United States	26	558 0.3×	632 0.4×	584 0.5×	989 0.9×	1.0k 0.9×	48	2.4k

Countries citing papers authored by Annette Staebler

Since Specialization

Citations

This map shows the geographic impact of Annette Staebler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Staebler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Staebler more than expected).

Fields of papers citing papers by Annette Staebler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Staebler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Staebler. The network helps show where Annette Staebler may publish in the future.

Co-authorship network of co-authors of Annette Staebler

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Staebler. A scholar is included among the top collaborators of Annette Staebler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Staebler. Annette Staebler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strauß, Alexander, Simon Thiele, Tobias Haist, et al.. (2025). Bimodal tissue differentiation using hyperspectral imaging and elastographic Fourier transform profilometry. Light Advanced Manufacturing. 6(4). 1–1.

Lou, Emil, Marcel Grube, Axel Svedbom, et al.. (2024). Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer. JAMA Network Open. 7(2). e240407–e240407. 13 indexed citations

Okumura, Toshiyuki, J Pasternak, Zhiqi Yang, et al.. (2024). Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells. International Journal of Molecular Sciences. 25(7). 3666–3666. 5 indexed citations

Grube, Marcel, Karen F. Greif, Annette Staebler, et al.. (2024). Diagnostics and Surgical Treatment of Deep Endometriosis—Real-World Data from a Large Endometriosis Center. Journal of Clinical Medicine. 13(22). 6783–6783. 1 indexed citations

Schönfisch, Birgitt, et al.. (2024). A Cohort of 469 Mayer–Rokitansky–Küster–Hauser Syndrome Patients—Associated Malformations, Syndromes, and Heterogeneity of the Phenotype. Journal of Clinical Medicine. 13(2). 607–607. 3 indexed citations

Taran, Florin‐Andrei, J Pasternak, Annette Staebler, et al.. (2023). Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center. Cancers. 15(16). 4110–4110. 4 indexed citations

Schroeder, Christopher, Olga Kelemen, Tobias Engler, et al.. (2022). 2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer. International Journal of Gynecological Cancer. 32. A40–A40. 1 indexed citations

Marzi, Julia, Matthias B. Stope, Melanie Henes, et al.. (2022). Noninvasive Physical Plasma as Innovative and Tissue-Preserving Therapy for Women Positive for Cervical Intraepithelial Neoplasia. Cancers. 14(8). 1933–1933. 29 indexed citations

Krämer, Bernhard, Elena Ioana Braicu, Bastian Czogalla, et al.. (2022). Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database. Archives of Gynecology and Obstetrics. 307(4). 1155–1162. 3 indexed citations

10.

Dannehl, Dominik, Tobias Engler, Annette Staebler, et al.. (2022). Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting—Results of the IRMA Trial. Cancers. 14(21). 5365–5365. 5 indexed citations

11.

Koch, André, Annette Staebler, Andreas D. Hartkopf, et al.. (2022). Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. Cancers. 14(18). 4542–4542. 1 indexed citations

12.

Kaltofen, Till, Stephan A. Eisler, Sven� Mahner, et al.. (2021). Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development. Cancers. 13(15). 3801–3801. 8 indexed citations

13.

Rensburg, Ruan van, Ellen Honisch, Martina Rudelius, et al.. (2019). EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM. Molecular Cancer Research. 18(2). 278–286. 8 indexed citations

14.

Loibl, Sibylle, Karsten E. Weber, Jens Huober, et al.. (2018). Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor. Clinical Cancer Research. 24(14). 3358–3365. 8 indexed citations

15.

Malpica, Anaís, Elizabeth D. Euscher, Jonathan L. Hecht, et al.. (2018). Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists. International Journal of Gynecological Pathology. 38(Supplement 1). S9–S24. 51 indexed citations

16.

Schmitz, Jennifer, Julian Schwab, Johannes Schwenck, et al.. (2016). Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study. Cancer Research. 76(18). 5512–5522. 27 indexed citations

17.

Bareiss, Petra M., Anna Paczulla, Hui Wang, et al.. (2013). SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma. Cancer Research. 73(17). 5544–5555. 126 indexed citations

18.

Scheble, Veit, Petra M. Bareiss, Anna Fischer, et al.. (2013). SOX2 Expression and Prognostic Significance in Ovarian Carcinoma. International Journal of Gynecological Pathology. 32(4). 358–367. 32 indexed citations

19.

Weis, Nicole, Monika Holeiter, Annette Staebler, et al.. (2012). Loss of the Ceramide Transfer Protein Augments EGF Receptor Signaling in Breast Cancer. Cancer Research. 72(11). 2855–2866. 33 indexed citations

20.

Staebler, Annette & Joachim Diebold. (2007). Molekularpathologie der epithelialen Ovarialneoplasien: Von der Phänotyp-Genotyp-Korrelation zu neuen Ansatzpunkten in Diagnostik und Therapie. Der Pathologe. 28(3). 180–186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact